The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model
- 1 March 2007
- journal article
- Published by Elsevier in Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis
- Vol. 616 (1-2) , 201-209
- https://doi.org/10.1016/j.mrfmmm.2006.11.025
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damageMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2006
- Mammary Tumorigenesis following Transgenic Expression of a Dominant Negative CHK2 MutantCancer Research, 2006
- Tumour characteristics and prognosis of breast cancer patients carrying the germline CHEK2*1100delC variantJournal of Medical Genetics, 2004
- The CHEK2 c.1100delC mutation plays an irrelevant role in breast cancer predisposition in ItalyHuman Mutation, 2004
- CHEK2*1100delC and male breast cancer risk in IsraelInternational Journal of Cancer, 2003
- Role of CHEK2*1100delC in unselected series of non‐BRCA1/2 male breast cancersInternational Journal of Cancer, 2003
- CHEK2 1100delC is not a risk factor for male breast cancer populationInternational Journal of Cancer, 2003
- Mutations in CHEK2 Associated with Prostate Cancer RiskAmerican Journal of Human Genetics, 2003
- DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociationNature, 2003
- Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutationsNature Genetics, 2002